Doing nothing is doing something: primary care antidepressant treatment in the era of FDA boxed warnings.
نویسندگان
چکیده
From the psychiatry service program at the North Florida/ South Georgia Veterans Health System in Gainesville, Florida (Dr Lacy); the Department of Psychiatry & Behavioral Sciences at the Keck School of Medicine of the University of Southern California in Los Angeles (Drs Baron, Goin, and Gross); the Department of Psychiatry at New York University in New York (Dr Slaby); and the BioBehavioral Diagnostics Company in Cambridge, Massachusetts, and the Department of Medicine and Psychiatry at the West Virginia University School of Medicine in Lewisburg (Dr Sumner).
منابع مشابه
-
The development and evolution of any system–person, organization–nation depends on how the system succeeds to bridge the gap between what the system knows and what the system does (with the knowledge). We call this the gap between knowing and doing or the knowing-doing gap. If the system does not do what it knows, it will lose out in competition with other systems, its relative performance in...
متن کاملSummaries of safety labeling changes approved by FDA-Boxed warnings highlights, January-March 2017.
As part of FDA’s MedWatch program, important changes to the safety labeling of drugs and therapeutic biologics, including boxed warnings, are posted on the agency’s website. Boxed warnings are ordinarily used to highlight (1) an adverse reaction so serious in proportion to the potential benefit from the drug that it is essential that the reaction be considered in assessing the risks and benefit...
متن کاملPersisting decline in depression treatment after FDA warnings.
CONTEXT In October 2003 the Food and Drug Administration (FDA) issued a Public Health Advisory about the risk of suicidality for pediatric patients taking antidepressants; a boxed warning, package insert, and medication guide were implemented in February 2005. The warning was extended to young adults aged 18 to 24 years in May 2007. Immediately following the 2003 advisory, unintended declines i...
متن کاملAntidepressants and Suicide Risk: Considerations in Treating Patients with Major Depression
Hospital Physician May 2008 15 F or nearly 2 decades, there has been concern regarding the relationship between antidepressants and risk for suicide. This concern ultimately led the US Food and Drug Administration (FDA) to issue a public health advisory in 2004 warning of a possible increased risk of suicide in children and adolescents treated with certain antidepressant drugs.1 In October 2004...
متن کاملPractical Considerations for Prescribing Benzodiazepines and Opioids.
INTRODUCTION The Food and Drug Administration is responsible for evaluating and approving the medications we prescribe. The FDA reviews post-market experience and monitors adverse drug reactions or unexpected effects. One of the strictest warnings the FDA can apply to a medication is a Boxed warning or Black Box warning. “Drugs that have special problems, particularly ones that may lead to deat...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- The Journal of the American Osteopathic Association
دوره 113 2 شماره
صفحات -
تاریخ انتشار 2013